Abstract
Barbiturates are central nervous system depressants with sedative and hypnotic properties. Some barbiturates, with longer half-lives, are used as anticonvulsants. Their mechanism of action includes activation of γ-aminobutyric acid (GABA) mediated neuronal transmission inhibition. Clinically used barbiturates include amobarbital, butalbital, pentobarbital, phenobarbital, secobarbital, and thiopental. Besides their therapeutic use, barbiturates are commonly abused. Their analysis is useful for both clinical and forensic proposes. Gas chromatography mass spectrometry is a commonly used method for the analysis of barbiturates. In the method described here, barbiturates from serum, plasma, or urine are extracted using an acidic phosphate buffer and methylene chloride. Barbital is used as an internal standard. The organic extract is dried and reconstituted with mixture of trimethylanilinium hydroxide (TMAH) and ethylacetate. The extract is injected into a gas chromatogram mass spectrometer where it undergoes “flash methylation” in the hot injection port. Selective ion monitoring and relative retention times are used for the identification and quantitation of barbiturates.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Lopez-Munoz, F., Ucha-Udabe, R. and Alamo, C. (2005) The history of barbiturates a century after their clinical introduction. Neuropsychiatr Dis Treat, 1, 329–43.
Smith, M.C. and Riskin, B.J. (1991) The clinical use of barbiturates in neurological disorders. Drugs, 42, 365–78.
Coupey, S.M. (1997) Barbiturates. Pediatr Rev, 18, 260–4; quiz 265.
Morgan, W.W. (1990) Abuse liability of barbiturates and other sedative-hypnotics. Adv Alcohol Subst Abuse, 9, 67–82.
Charlier, C.J. and Plomteux, G.J. (2000) Evaluation of Emit tox benzodiazepine and barbiturate assays on the Vitalab Viva analyser and FPIA on the Abbott ADx analyser. Clin Chem Lab Med, 38, 615–8.
Cannon, R.D., Wong, S.H., Gock, S.B. and Jentzen, J.J. (1999) Comparison of the serum barbiturate fluorescence polarization immunoassay by the COBAS INTEGRA to a GC/MS method. Ther Drug Monit, 21, 553–8.
Adamczyk, M., Douglas, J., Grote, J. and Harrington, C.A. (1998) A barbiturate screening assay for the Abbott AxSYM analyzer. J Anal Toxicol, 22, 105–11.
Hall, B.J. and Brodbelt, J.S. (1997) Determination of barbiturates by solid-phase microextraction (SPME) and ion trap gas chromatography-mass spectrometry. J Chromatogr A, 777, 275–82.
Meatherall, R. (1997) GC/MS confirmation of barbiturates in blood and urine. J Forensic Sci, 42, 1160–70.
Liu, R.H., McKeehan, A.M., Edwards, C., Foster, G., Bensley, W.D., Langner, J.G. and Walia, A.S. (1994) Improved gas chromatography/mass spectrometry analysis of barbiturates in urine using centrifuge-based solid-phase extraction, methylation, with d5-pentobarbital as internal standard. J Forensic Sci, 39, 1504–14.
DeGraeve, J. and Vanroy, J. (1976) Simultaneous determination of methylated barbiturates and other anticonvulsant drugs by high-resolution gas chromatography. J Chromatogr, 129, 171–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Johnson, L.L., Garg, U. (2010). Quantitation of Amobarbital, Butalbital, Pentobarbital, Phenobarbital, and Secobarbital in Urine, Serum, and Plasma Using Gas Chromatography-Mass Spectrometry (GC-MS). In: Garg, U., Hammett-Stabler, C. (eds) Clinical Applications of Mass Spectrometry. Methods in Molecular Biology, vol 603. Humana Press. https://doi.org/10.1007/978-1-60761-459-3_7
Download citation
DOI: https://doi.org/10.1007/978-1-60761-459-3_7
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-458-6
Online ISBN: 978-1-60761-459-3
eBook Packages: Springer Protocols